These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is the apparent outbreak of hepatitis A in Belgian hemophiliacs due to a loss of previous passive immunity? Peerlinck K, Goubau P, Coppens G, Desmyter J, Vermylen J. Vox Sang; 1994; 67 Suppl 1():14-6; discussion 17. PubMed ID: 8091728 [Abstract] [Full Text] [Related]
3. Review of the hepatitis A epidemics in hemophiliacs in Europe. Vermylen J, Peerlinck K. Vox Sang; 1994; 67 Suppl 4():8-11; discussion 24-6. PubMed ID: 7831867 [Abstract] [Full Text] [Related]
4. The outbreak of hepatitis A in Italian patients with hemophilia: facts and fancies. Mannucci PM, Santagostino E, Di Bona E, Gentili G, Ghirardini A, Schiavoni M, Mele A. Vox Sang; 1994; 67 Suppl 1():31-5. PubMed ID: 8091734 [Abstract] [Full Text] [Related]
5. Hepatitis A virus infection among the hemophilia population at the Bonn Hemophilia Center. Brackmann HH, Oldenburg J, Eis-Hübinger AM, Gerritzen A, Hammerstein U, Hanfland P. Vox Sang; 1994; 67 Suppl 1():3-7; discussion 8. PubMed ID: 8091733 [Abstract] [Full Text] [Related]
11. Virology of the hepatitis A epidemic in Italy. Purcell RH, Mannucci PM, Gdovin S, Gringeri A, Colombo M, Mele A, Schinaia N, Ciavarella N, Emerson SU. Vox Sang; 1994; 67 Suppl 4():2-7; discussion 24-6. PubMed ID: 7831866 [Abstract] [Full Text] [Related]
13. Has hepatitis A virus been transmitted by clotting factor concentrates among hemophiliacs in the United States? Mosley JW. Vox Sang; 1994; 67 Suppl 4():12-5; discussion 24-6. PubMed ID: 7831863 [Abstract] [Full Text] [Related]
14. Clotting factors and hepatitis A. Temperley IJ, Cotter KP, Walsh TJ, Power J, Hillary IB. Lancet; 1992 Dec 12; 340(8833):1466. PubMed ID: 1360577 [No Abstract] [Full Text] [Related]
16. Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma-derived FVIII or FIX concentrate: results from the French haemophilia cohort. Gaboulaud V, Parquet A, Tahiri C, Claeyssens S, Potard V, Faradji A, Peynet J, Costagliola D, Suivi Thérapeutique National des Hémophiles Group. Br J Haematol; 2002 Feb 12; 116(2):383-9. PubMed ID: 11841442 [Abstract] [Full Text] [Related]
17. Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate. Gringeri A, Monzini M, Tagariello G, Scaraggi FA, Mannucci PM, Emoclot15 Study Members. Haemophilia; 2006 Mar 12; 12(2):128-32. PubMed ID: 16476086 [Abstract] [Full Text] [Related]